Comparison of pain after abdominal surgery in patients receiving Nasocalcin spray or vitamin D and Nasocalcin spray

Determining the amount of pain after abdominal surgery in patients receiving nasocalcin spray or vitamin D and nasocalcin spray in patients referred to the hospitals of Tehran Islamic Azad University of Medical Sciences in 2021

A double-blind clinical trial, with parallel groups, randomized, phase 2 on 34 patients, for randomization, first a list of patients who were willing to participate in the research was prepared and after matching the individuals, we assigned a number to each patient and They were randomly placed in two groups according to the table of random numbers

The drugs were divided by the head of the surgery department as A/B (A received nasocalcin spray and distilled water intramuscularly and B received nasocalcin spray and vitamin D intramuscularly). The doctor and the patient were not aware of which group the patient was in. Medicines were prescribed to the patients when they entered the operating room and in the recovery room. The method of calculating the amount of medicine and spray puffs in the patients was as follows: weight less than or equal to 60 kg, one puff of nasocalcin spray Weight more than 60 kg, two puffs of Nasocalcin spray Two cc intramuscular distilled water Intramuscular Vitamin D Ampoule

Inclusion age15-75years Signing a personal and informed consent form to participate in the study ASA1and2 Non-use of drugs and alcohol Elective surgery Exclusion Loss of consciousness Hemodynamic disorder Abnormal intraoperative bleeding operation more than4hours

Medicines were administered to the patients upon entering the operating room and in the recovery room.

Postoperative pain in recovery and 6, 12, 24 hours after the operation, the pain level of the patients was checked based on the VAS pattern

In this study, a list of all patients who were willing to participate in the study was first prepared, and after matching the patients who met the inclusion criteria, we assigned a number to each patient. We considered numbers 1 to 17 as group A and 18 to 34 as group B. Then, using an online random number table, the patients were placed in two groups (A group receiving nasocalcin spray and B group receiving vitamin D and nasocalcin spray).

In order to be double-blinded (patients and researchers did not know which patients were placed in which group), the drugs used for patients (nasocalcin spray or vitamin D and nasocalcin spray) at the beginning of the study by the head of the surgery department in two containers with the same appearance It was divided and named as A/B (A included nasocalcin spray and B included vitamin D and nasocalcin spray). Before the operation, drugs from one of the containers were randomly prescribed to the patient by the nurse of the surgery department and recorded in the data collection form by the relevant nurse.

There is no further information